Morning administration may be preferable for patients who experience nausea, as they can manage symptoms during waking hours when they can employ coping strategies such as eating small, low-fat meals, staying hydrated, or using anti-nausea medications if prescribed
We forecast one to two GLP-1 launches annually starting in 2026, with the first oral entrant expected by 2027
Adverse Reactions Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice
Orthopedic surgeons need to be cognizant of patients on GLP-1 agonists and council them that they may experience more postoperative nausea and vomiting than patients not taking the medication, Sara E
TrimRx is open about how treatments work, what to expect, and how success is measured